JP2011507498A5 - - Google Patents

Download PDF

Info

Publication number
JP2011507498A5
JP2011507498A5 JP2010538889A JP2010538889A JP2011507498A5 JP 2011507498 A5 JP2011507498 A5 JP 2011507498A5 JP 2010538889 A JP2010538889 A JP 2010538889A JP 2010538889 A JP2010538889 A JP 2010538889A JP 2011507498 A5 JP2011507498 A5 JP 2011507498A5
Authority
JP
Japan
Prior art keywords
fusion protein
nucleic acid
aggrecanase
tgfβ
pharmaceutically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010538889A
Other languages
English (en)
Japanese (ja)
Other versions
JP5683272B2 (ja
JP2011507498A (ja
Filing date
Publication date
Priority claimed from GBGB0724556.6A external-priority patent/GB0724556D0/en
Application filed filed Critical
Publication of JP2011507498A publication Critical patent/JP2011507498A/ja
Publication of JP2011507498A5 publication Critical patent/JP2011507498A5/ja
Application granted granted Critical
Publication of JP5683272B2 publication Critical patent/JP5683272B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010538889A 2007-12-17 2008-12-17 アグリカナーゼ感受性切断部位を有する潜在関連タンパク質構築物 Expired - Fee Related JP5683272B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0724556.6A GB0724556D0 (en) 2007-12-17 2007-12-17 LAtency associated protein construct with aggrecanase sensitive cleavage site
GB0724556.6 2007-12-17
PCT/GB2008/004167 WO2009077755A2 (en) 2007-12-17 2008-12-17 Latency associated protein construct with aggrecanase sensitive cleavage site

Publications (3)

Publication Number Publication Date
JP2011507498A JP2011507498A (ja) 2011-03-10
JP2011507498A5 true JP2011507498A5 (enExample) 2013-02-14
JP5683272B2 JP5683272B2 (ja) 2015-03-11

Family

ID=39048208

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010538889A Expired - Fee Related JP5683272B2 (ja) 2007-12-17 2008-12-17 アグリカナーゼ感受性切断部位を有する潜在関連タンパク質構築物

Country Status (7)

Country Link
US (1) US8357515B2 (enExample)
EP (1) EP2262540B1 (enExample)
JP (1) JP5683272B2 (enExample)
DK (1) DK2262540T3 (enExample)
ES (1) ES2552018T3 (enExample)
GB (1) GB0724556D0 (enExample)
WO (1) WO2009077755A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3004154A4 (en) * 2013-06-05 2017-01-04 Ben Gurion University of The Negev Research and Development Authority IL-1beta-IL-1Ra CHIMERA AND METHODS OF USING THE SAME
GB201411506D0 (en) 2014-06-27 2014-08-13 Univ London Queen Mary Modified latency associated protein construct
JP6516235B2 (ja) * 2014-10-31 2019-05-22 国立大学法人富山大学 キメラタンパク質及びそれを用いたミクログリア活性阻害剤
ES2780274A1 (es) 2019-02-15 2020-08-24 Consejo Superior De Investig Científicas (Csic) Cortistatina o un análogo de la misma como agente farmacéuticamente activo en forma latente
GB202004679D0 (en) 2020-03-31 2020-05-13 Stealthyx Therapeutics Ltd Modified latercy associated protein construct

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4103002A (en) * 1977-02-08 1978-07-25 Board Of Regents, University Of Florida Bioglass coated A1203 ceramics
US4234972A (en) * 1978-06-21 1980-11-25 Board Of Regents, State Of Florida Bioglass coated metal substrate
US4725234A (en) * 1985-08-15 1988-02-16 Ethridge Edwin C Alveolar bone grafting process with controlled surface active ceramics
DE3907663A1 (de) * 1989-03-09 1990-09-13 Espe Stiftung Knochenersatzteil aus glasionomerzement
FR2651439B1 (fr) * 1989-09-06 1994-09-23 Fbfc International Sa Nv Materiau bioreactif pour prothese ou implants composites.
US5074916A (en) * 1990-05-18 1991-12-24 Geltech, Inc. Alkali-free bioactive sol-gel compositions
JP2807752B2 (ja) 1993-05-17 1998-10-08 ティーディーケイ株式会社 結晶化ガラス材
GB9319971D0 (en) 1993-09-28 1993-11-17 Cookson Group Plc Cobalt glass compositions for coatings
US5679338A (en) * 1994-05-12 1997-10-21 Osteoarthritis Science, Inc. Use of IL-4 for inhibition of the breakdown of articular cartilage and other tissues
FI101129B (sv) 1995-01-13 1998-04-30 Vivoxid Oy Nya bioaktiva glas och deras användning
US6224913B1 (en) * 1996-05-09 2001-05-01 The Trustees Of The University Of Pennsylvania Conditioning of bioactive glass surfaces in protein containing solutions
FR2749759B1 (fr) * 1996-06-17 1999-11-26 Adir Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose
WO1998017236A1 (en) 1996-10-23 1998-04-30 Sunstar Inc. Oral preparations containing biologically active crystallized glass
CZ295421B6 (cs) 1997-03-13 2005-08-17 Saint-Gobain Vitrage Kompozice na bázi křemičito-sodno-vápenatého skla a jejich použití
ATE302621T1 (de) * 1999-06-14 2005-09-15 Imp College Innovations Ltd Silberhaltige bioglas-zusammensetzungen, die von sol-gel zuständen abgeleitet werden
GB0100551D0 (en) * 2001-01-09 2001-02-21 Queen Mary & Westfield College Protein
US7141392B2 (en) * 2001-01-09 2006-11-28 Queen Mary And Westfield College Latent fusion protein
DE10111449A1 (de) * 2001-03-09 2002-09-26 Schott Glas Verwendung von bioaktivem Glas in Zahnfüllmaterial
WO2004071542A1 (en) 2003-02-14 2004-08-26 The North West London Hospitals Nhs Trust Bioactive material for use in stimulating vascularization
DE112004000094A5 (de) * 2003-02-25 2008-04-03 Schott Ag Antimikrobiell wirkendes Borosilicatglas
US6905723B2 (en) * 2003-05-30 2005-06-14 Depuy Products, Inc. Strontium-substituted apatite coating
CN1292804C (zh) 2004-03-08 2007-01-03 西安交通大学 含锶纳米磷酸钙生物活性骨水泥的制备工艺
DE102004026432A1 (de) * 2004-05-29 2005-12-22 Schott Ag Glaszusammensetzungen als antimikrobieller Zusatz für Dentalmaterialien und deren Verwendung
WO2006050829A1 (en) 2004-11-12 2006-05-18 Dentsply De Trey Gmbh Dental glass composition
WO2007020613A1 (en) 2005-08-12 2007-02-22 University Of Limerick A synthetic graft having a glass network
DE102006036019A1 (de) 2006-08-02 2008-02-07 Pemeas Gmbh Membran-Elektroden-Einheit und Brennstoffzellen mit erhöhter Leistung
WO2008090533A2 (en) 2007-01-26 2008-07-31 University Of Limerick A bone cement

Similar Documents

Publication Publication Date Title
US12173060B2 (en) Compositions and methods of use for treating metabolic disorders
RU2011138951A (ru) Пропротеины и способы их применения
JP2021521822A5 (enExample)
DK1349944T3 (da) Latensassocieret peptid af TGF-beta til at bibringe farmaceutisk aktive proteiner latens
JP2004504032A5 (enExample)
WO2017025698A1 (en) Bispecific, cleavable antibodies
WO2010115998A3 (en) Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
JP2004520031A5 (enExample)
CA2795168A1 (en) Factor xii inhibitors for treating interstitial lung disease
JP2008521426A5 (enExample)
TW200526780A (en) TNF antagonists and TNF inhibitors comprising the same as the active ingredient
JP2025521082A5 (enExample)
JP2024513559A5 (enExample)
JP2013529178A5 (enExample)
UA91820C2 (ru) Терапевтическое применение вариантов хемокинов
JP2024538706A5 (enExample)
WO2022271863A1 (en) Coronavirus neutralizing compositions and associated methods
JP2017526625A5 (enExample)
JP2025510591A5 (enExample)
WO2006018450A3 (en) Pharmaceutically active insulin receptor-modulating molecules
AU2024372189A1 (en) Multi-chain chimeric polypeptides and uses thereof
CA2961587C (en) Compositions and methods of use for treating metabolic disorders
WO2023196916A1 (en) Methods of treating of hidradenitis suppurativa
JP2001269184A5 (enExample)
HK40035218A (en) Compositions and methods of use for treating metabolic disorders